fluorodeoxyglucose f18 has been researched along with ioversol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chasen, M; Erasmus, JJ; Knight, AE; Macapinlac, HA; Mawlawi, O; Munden, RF; Pan, T; Podoloff, DA | 1 |
| Davison, JM; Grillone, GA; Imsande, HM; Ozonoff, A; Subramaniam, RM | 1 |
| Bleichrodt, R; Boerman, O; de Jong, G; Franssen, G; Hendriks, T; Oyen, W | 1 |
| Davison, JM; Devaiah, AK; Imsande, HM; Mercier, GA; Ozonoff, AJ; Subramaniam, RM; Truong, MT | 1 |
| Hadiprodjo, D; Mercier, G; Ryan, T; Subramaniam, RM; Truong, MT | 1 |
| Balachandran, A; Bhosale, P; Katz, M; Rayamajhi, S; Reddy, A; Rohren, E | 1 |
6 other study(ies) available for fluorodeoxyglucose f18 and ioversol
| Article | Year |
|---|---|
Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.
Topics: Contrast Media; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Subclavian Vein; Tomography, Emission-Computed; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2006 |
Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Carcinoma, Squamous Cell; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Palatine Tonsil; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Spiral Computed; Tonsillar Neoplasms; Triiodobenzoic Acids | 2010 |
Adjuvant radioimmunotherapy after radiofrequency ablation of colorectal liver metastases in an experimental model.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Liver Neoplasms; Lutetium; Male; Octreotide; Positron-Emission Tomography; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Rats; Reproducibility of Results; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2011 |
Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2011 |
Parotid gland tumors: preliminary data for the value of FDG PET/CT diagnostic parameters.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Case-Control Studies; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Parotid Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2012 |
Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; CA-19-9 Antigen; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2018 |